Promising E. Coli Vaccine Fizzles in Late-Stage Trial
(MedPage Today) -- An investigational vaccine targeting the Escherichia coli pathogens that commonly cause infections didn't show a protective effect in older adults, the phase III E.mbrace trial found. Among over 17,000 participants ages 60 and...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.